The spectrum of hearing loss due to mitochondrial DNA defects

Brain

Volumn 123, Issue 1, 2000, Pages 82-92

  Chinnery, Patrick F ^a,c   Elliott, Clive ^b   Green, Gary R ^a   Rees, Adrian ^a   Coulthard, Alan ^a   Turnbull, Douglas M ^a   Griffiths, Timothy D ^a  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

^b FREEMAN HOSPITAL   (United Kingdom)

^c NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

Genetic hearing loss; Mitochondrial encephalomyopathies; Mitochondrial hearing loss; MtDNA mutation

Indexed keywords

MITOCHONDRIAL DNA;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; COCHLEA; DISEASE SEVERITY; ENCEPHALOMYOPATHY; EVOKED BRAIN STEM AUDITORY RESPONSE; FEMALE; HEARING IMPAIRMENT; HEARING LOSS; HUMAN; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; OTOACOUSTIC EMISSION; POINT MUTATION; PRIORITY JOURNAL; PURE TONE AUDIOMETRY;

EID: 0033976931     PISSN: 00068950     EISSN: None     Source Type: Journal    
DOI: 10.1093/brain/123.1.82     Document Type: Article

References (59)

1. Abramovich S. Electric response audiometry in clinical practice. Edinburgh: Churchill Livingstone; 1990.
2. Bidooki SK, Johnson MA, Chrzanowska-Lightowlers Z, Bindoff LA, Lightowlers RN. Intracellular mitochondrial triplasmy in a patient with two heteroplasmic base changes. Am J Hum Genet 1997; 60: 1430-8.
3. Braverman I, Jaber L, Levi H, Adelman C, Arons K, Fischel-Ghodsian N, et al. Audiovestibular findings in patients with deafness caused by a mitochondrial susceptibility mutation and precipitated by an inherited nuclear mutation or aminoglycosides. Arch Otolaryngol Head Neck Surg 1996; 122: 1001-4.
4. British Society of Audiology. Recommended procedures for puretone audiometry using a manually operated instrument. Br J Audiol 1981; 15: 213-6.
5. British Society of Audiology. Recommended procedure for puretone bone-conduction audiometry without masking using a manually operated instrument. Br J Audiol 1985; 19: 281-2.
6. British Society of Audiology. Recommendations for masking in pure tone threshold audiometry. Br J Audiol 1986; 20: 307-14.
7. Chinnery PF, Turnbull DM. Clinical features, investigation and management of patients with defects of mitochondrial DNA [editorial]. [Review]. J Neurol Neurosurg Psychiatry 1997; 63: 559-63.
8. Chinnery PF, Turnbull DM. Mitochondrial genotype and clinical phenotype. [Review]. J Inherit Metab Dis 1998; 21: 321-5.
9. Chinnery PF, Johnson MA, Taylor RW, Lightowlers RN, Turnbull DM. A novel mitochondrial tRNA phenylalanine mutation presenting with acute rhabdomyolysis. Ann Neurol 1997; 41: 408-10.
10. Chomyn A, Martinuzzi A, Yoneda M, Daga A, Hurko O, Johns D, et al. MELAS mutation in mtDNA binding site for transcription termination factor causes defects in protein synthesis and in respiration but no change in levels of upstream and downstream mature transcripts. Proc Natl Acad Sci USA 1992; 89: 4221-5.
11. Cortopassi G, Hutchin T. A molecular and cellular hypothesis for aminoglycoside-induced deafness. [Review]. Hear Res 1994; 78: 27-30.
12. Dallos P, Evans BN. High-frequency motility of outer hair cells and the cochlear amplifier. Science 1995; 267: 2006-9.
13. Davis A. Hearing in adults. London: Whurr; 1995.
14. DiMauro S, Bonilla E. Mitochondrial encephalomyopathies. In: Rosenberg RN, Prusiner SB, DiMauro S, Barchi RL, editors. The molecular and genetic basis of neurological disease. Boston: Butterworth-Heinemann; 1997. p. 201-35.
15. Elverland HH, Torbergsen T. Audiologic findings in a family with mitochondrial disorder. Am J Otol 1991; 12: 459-65.
16. Estivill X, Govea N, Barcelo A, Badenas C, Romero E, Moral L, et al. Familial progressive sensorineural deafness is mainly due to the mtDNA A1555G mutation and is enhanced by treatment with aminoglycosides. Am J Hum Genet 1998; 62: 27-35.
17. Fernandez C, Hinojosa R. Postnatal development of endocochlear potential and stria vascularis in the cat. Acta Otolaryngol (Stockh) 1974; 78: 173-86.
18. Fischel-Ghodsian N. Mitochondrial mutations and hearing loss: paradigm for mitochondrial genetics [editorial]. [Review]. Am J Hum Genet 1998; 62: 15-19.
19. Fischel-Ghodsian N, Bykhovskaya Y, Taylor K, Kahen T, Cantor R, Ehrenman K, et al. Temporal bone analysis of patients with presbycusis reveals high frequency of mitochondrial mutations. Hear Res 1997; 110: 147-54.
20. Goto Y, Nonaka I, Horai S. A mutation in the tRNA(Leu)(UUR) gene associated with the MELAS subgroup of mitochondrial encephalomyopathies. Nature 1990; 348: 651-3.
21. Griffiths TD, Bates D, Rees A, Witton C, Gholkar A, Green GG. Sound movement detection deficit due to a brainstem lesion. J Neurol Neurosurg Psychiatry 1997; 62: 522-6.
22. Griffiths TD, Elliott C, Coulthard A. Cartlidge NE, Green GG. A distinct low-level mechanism for interaural timing analysis in human hearing. Neuroreport 1998; 9: 3383-6.
23. Griffiths TD, Rees A, Green GGR. Disorders of human complex sound processing. [Review]. Neurocase. In press 1999.
24. Hibino H, Horio Y, Inanobe A, Doi K, Ito M, Yamada M, et al. An ATP-dependent inwardly rectifying potassium channel, KAB-2 (Kir4.1), in cochlear stria vascularis of inner ear: its specific subcellular localization and correlation with the formation of endocochlear potential. J Neurosci 1997; 17: 4711-21.
25. Holt IJ, Harding AE, Petty RK, Morgan-Hughes JA. A new mitochondrial disease associated with mitochondrial DNA heteroplasmy. Am J Hum Genet 1990; 46: 428-33.
26. Howell N. Human mitochondrial diseases: answering questions and questioning answers. Int Rev Cytol 1999; 186: 49-116.
27. Hyde GE, Rubel EW. Mitochondrial role in hair cell survival after injury. Otolaryngol Head Neck Surg 1995; 113: 530-40.
28. Johnson MA, Barron MJ. Muscle biopsy analysis. In: Lane RJM, editor. Handbook of muscle disease. New York: Marcel Dekker; 1996. p. 61-79.
29. Kemp DT. Stimulated acoustic emissions from within the human auditory system. J Acoust Soc Am 1978; 64: 1386-91.
30. Larsson N-G, Clayton DA. Molecular genetic aspects of human mitochondrial disorders. [Review]. Annu Rev Genet 1995; 29: 151-78.
31. Lightowlers RN, Chinnery PF, Turnbull DM, Howell N. Mammalian mitochondrial genetics: heredity, heteroplasmy and disease. [Review]. Trends Genet 1997; 11: 450-5.
32. Lindsay JR, Hinojosa R. Histopathologic features of the inner ear associated with Kearns-Sayre syndrome. Arch Otolaryngol 1976; 102: 747-52.
33. Majamaa K, Turkka J, Karppa M, Winqvist S, Hassinen IE. The common MELAS mutation A3243G in mitochondrial DNA among young patients with an occipital brain infarct. Neurology 1997; 49: 1331-4.
34. Majamaa K, Moilanen JS, Uimonen S, Remes AM, Salmela PI, Karppa M, et al. Epidemiology of A3243G, the mutation for mitochondrial encephalomyopathy, lactic acidosis, and stroke like episodes: prevalence of the mutation in an adult population. Am J Hum Genet 1998; 63: 447-54.
35. Martin WH, Schwegler JW, Gleeson AL, Shi YB. New techniques of hearing assessment. [Review]. Otolaryngol Clin North Am 1994; 27: 487-510.
36. Moraes CT, DiMauro S, Zeviani M, Lombes A, Shanske S, Miranda AF, et al. Mitochondrial DNA deletions in progressive external ophthalmoplegia and Kearns-Sayre syndrome. N Engl J Med 1989; 320: 1293-9.
37. Moraes CT, Ciacci F, Silvestri G, Shanske S, Sciacco M, Hirano M, et al. Atypical clinical presentations associated with the MELAS mutation at position 3243 of human mitochondrial DNA. Neuromuscul Disord 1993; 3: 43-50.
38. Oshima T, Ueda N, Ikeda K, Abe K, Takasaka T. Bilateral sensorineural hearing loss associated with the point mutation in mitochondrial genome. Laryngoscope 1996; 106: 43-8.
39. Oshima T, Ikeda K, Ueda N, Takasaka T. Sensorineural hearing loss with a mitochondrial gene point mutation is highly prevalent in Japan. In: Association for Reasearch in Otolaryngology. St Petersburg, Florida; 1999. p. 11.
40. Prezant TR, Agapian JV, Bohlman MC, Bu X, Oztas S, Qiu W-Q, et al. Mitochondrial ribosomal RNA mutation associated with both antibiotic-induced and non-syndromic deafness. Nat Genet 1993; 4: 289-94.
41. Priede VM, Coles RRA. Speech discrimination tests in investigation of sensorineural hearing loss. J Laryngol Otol 1976; 90: 1081-92.
42. Reid FM, Vernham GA, Jacobs HT. A novel mitochondrial point mutation in a maternal pedigree with sensorineural deafness. Hum Mutat 1994; 3: 243-7.
43. Schon EA, Bonilla E, DiMauro S. Mitochondrial DNA mutations and pathogenesis. [Review]. J Bioenerg Biomembr 1997; 29: 131-49.
44. Seidman MD, Bai U, Khan MJ, Quirk WS. Mitochondrial DNA deletions associated with aging and presbyacusis. Arch Otolaryngol Head Neck Surg 1997; 123: 1039-45.
45. Servidei S. Mitochondrial encephalomyopathies: gene mutation. Neuromuscul Disord 1997; 8: XIII-IX.
46. Sparaco M, Bonilla E, DiMauro S, Powers JM. Neuropathology of mitochondrial encephalomyopathies due to mitochondrial DNA defects. [Review]. J Neuropathol Exp Neurol 1993; 52: 1-10.
47. Sue CM, Lipsett LJ, Crimmins DS, Tsang CS, Boyages SC, Presgrave CM, et al. Cochlear origin of hearing loss in MELAS syndrome. [Review]. Ann Neurol 1998; 43: 350-9.
48. 't Hart LM, Jansen JJ, Lemkes HH, de Knijff P, Maassen JA. Heteroplasmy levels of a mitochondrial gene mutation associated with diabetes mellitus decrease in leucocyte DNA upon aging. Hum Mutat 1996; 7: 193-7.
49. Tao ZZ, Yamashita T, Chou JT. Succinate dehydrogenase and mitochondria in the hair cells in the organ of Corti of mature and old shaker-1 mice. J Laryngol Otol 1987; 101: 643-51.
50. Taylor RW, Turnbull DM. Laboratory diagnosis of mitochondrial disease. In: Applegarth DA, Dimmick J, Hall JG, editors. Organelle diseases. London: Chapman & Hall; 1997. p. 341-50.
51. Taylor RW, Chinnery PF, Bates MJ, Jackson MJ, Johnson MA, Andrews RM, et al. A novel mitochondrial DNA point mutation in the tRNAIIe gene: studies in a patient presenting with chronic progressive external ophthalmoplegia and multiple sclerosis. Biochem Biophys Res Commun 1998; 243: 47-51.
52. Thalmann I, Marcus NY, Thalmann R. Adenine nucleotides of the stria vascularis. Arch Otorhinolaryngol 1979; 224: 89-95.
53. Thalmann I, Marcus NY, Thalmann R. Adenine nucleotides of the organ of Corti under metabolic stress. Laryngoscope 1982; 92: 199-203.
54. van den Ouweland JM, Lemkes HH, Ruitenbeek K, Sandkuijl LA, de Vijlder MF, Struyvenberg PA, et al. Mutation in mitochondrial tRNA Leu(UUR) gene in a large pedigree with maternally transmitted type II diabetes mellitus and deafness. Nat Genet 1992; 1: 368-71.
55. Wallace DC. Diseases of the mitochondrial DNA. [Review]. Annu Rev Biochem 1992a; 61: 1175-212.
56. Wallace DC. Mitochondrial genetics: a paradigm for aging and degenerative diseases? Science 1992b; 256: 628-32.
57. Weber K, Wilson JN, Taylor L, Brierley E, Johnson MA, Turnbull DM, et al. A new mtDNA mutation showing accumulation with time and restriction to skeletal muscle. Am J Hum Genet 1997; 60: 373-80.
58. Yamasoba T, Oka Y, Tsukuda K, Nakamura M, Kaga K. Auditory findings in patients with maternally inherited diabetes and deafness harboring a point mutation in the mitochondrial transfer RNA Leu(UUR) gene. Laryngoscope 1996; 106: 49-53.
59. Zeviani M, Moraes CT, DiMauro S, Nakase H. Bonilla E, Schon EA, et al. Deletions of mitochondrial DNA in Kearns-Sayre syndrome. Neurology 1988; 38: 1339-46.